NO20023654L - Linezolid-krystall form II - Google Patents

Linezolid-krystall form II

Info

Publication number
NO20023654L
NO20023654L NO20023654A NO20023654A NO20023654L NO 20023654 L NO20023654 L NO 20023654L NO 20023654 A NO20023654 A NO 20023654A NO 20023654 A NO20023654 A NO 20023654A NO 20023654 L NO20023654 L NO 20023654L
Authority
NO
Norway
Prior art keywords
crystal form
linezolid crystal
linezolid
crystal
Prior art date
Application number
NO20023654A
Other languages
English (en)
Other versions
NO323459B1 (no
NO20023654D0 (no
Inventor
Michael S Bergren
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22658183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20023654(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20023654D0 publication Critical patent/NO20023654D0/no
Publication of NO20023654L publication Critical patent/NO20023654L/no
Publication of NO323459B1 publication Critical patent/NO323459B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20023654A 2000-02-02 2002-08-01 (S)-N[[3-[3-fluor-4-(morfolinyl)fenyl]-2-okso-5-oksazolidinyl]metyl]acetamid ,krystall form II NO323459B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17983700P 2000-02-02 2000-02-02
PCT/US2001/000657 WO2001057035A1 (en) 2000-02-02 2001-01-29 Linezolid-crystal form ii

Publications (3)

Publication Number Publication Date
NO20023654D0 NO20023654D0 (no) 2002-08-01
NO20023654L true NO20023654L (no) 2002-08-01
NO323459B1 NO323459B1 (no) 2007-05-14

Family

ID=22658183

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20023654A NO323459B1 (no) 2000-02-02 2002-08-01 (S)-N[[3-[3-fluor-4-(morfolinyl)fenyl]-2-okso-5-oksazolidinyl]metyl]acetamid ,krystall form II
NO20065836A NO20065836L (no) 2000-02-02 2006-12-15 Linezolidkrystallform

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20065836A NO20065836L (no) 2000-02-02 2006-12-15 Linezolidkrystallform

Country Status (31)

Country Link
EP (1) EP1255754B1 (no)
JP (1) JP5235256B2 (no)
KR (3) KR20080044358A (no)
CN (1) CN1221547C (no)
AR (1) AR027261A1 (no)
AT (1) ATE297920T1 (no)
AU (1) AU782138B2 (no)
BR (1) BR0107667A (no)
CA (1) CA2395603C (no)
CO (1) CO5261555A1 (no)
CZ (1) CZ302292B6 (no)
DE (1) DE60111497T2 (no)
DK (1) DK1255754T3 (no)
EA (1) EA004434B1 (no)
EE (1) EE05197B1 (no)
ES (1) ES2242728T3 (no)
HK (1) HK1051196A1 (no)
HU (1) HUP0301076A3 (no)
IL (1) IL151010A0 (no)
MX (1) MXPA02007471A (no)
MY (1) MY122829A (no)
NO (2) NO323459B1 (no)
NZ (1) NZ520541A (no)
PE (1) PE20011086A1 (no)
PL (1) PL356433A1 (no)
PT (1) PT1255754E (no)
SI (1) SI1255754T1 (no)
SK (1) SK287025B6 (no)
TW (1) TWI297687B (no)
WO (1) WO2001057035A1 (no)
ZA (1) ZA200205162B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100490643B1 (ko) * 2002-10-29 2005-05-19 한국과학기술연구원 새로운 메틸리덴 피페리딘일 옥사졸리딘온 유도체 및이들의 제조방법
DK1673370T3 (da) 2003-10-16 2009-12-07 Symed Labs Ltd Krystallingsk form af linezolid
WO2005099353A2 (en) 2004-04-19 2005-10-27 Symed Labs Limited A novel process for the preparation of linezolid and related compounds
EP2174935A1 (en) * 2004-06-29 2010-04-14 Teva Pharmaceutical Industries Ltd Linezolid Compositions
MX2007000084A (es) * 2004-06-29 2007-06-14 Teva Pharma Formas solidas de linezolid y procesos para la preparacion delas mismas.
US7291614B2 (en) * 2005-02-24 2007-11-06 Teva Pharmaceutical Industries Ltd. Processes for the preparation of linezolid intermediate
EP1893195A2 (en) * 2005-06-22 2008-03-05 Teva Pharmaceutical Industries Ltd Polymorphic forms of tegaserod maleate
EP1749517B8 (en) * 2005-07-20 2008-10-22 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical composition comprising linezolid form IV
WO2007102082A1 (en) * 2006-03-09 2007-09-13 Glenmark Pharmaceuticals Limited High oxazolidinone content solid dosage forms
EP2099299A4 (en) * 2006-10-23 2011-11-30 Concert Pharmaceuticals Inc OXAZOLIDINONE DERIVATIVES AND METHOD FOR THEIR USE
WO2011050826A1 (en) 2009-10-28 2011-05-05 Synthon B.V. Process for making crystalline form a of linezolid
EP2563781B1 (en) 2010-04-30 2016-10-26 Indiana University Research and Technology Corporation Processes for preparing linezolid
EP2603506A1 (en) 2010-08-11 2013-06-19 Synthon BV Process for making linezolid
WO2012019632A1 (en) 2010-08-11 2012-02-16 Synthon B.V. Process for making linezolid
EP2593440A1 (en) * 2011-02-24 2013-05-22 Lee Pharma Limited Anhydrous linezolid crystalline form-ii
EP2683696A1 (en) 2011-03-09 2014-01-15 Synthon BV Process for making crystalline form a of linezolid
CN102731341A (zh) * 2011-04-13 2012-10-17 上海医药工业研究院 用于制备利奈唑胺的中间体及其制备方法
CN102766106A (zh) * 2011-05-03 2012-11-07 江苏豪森医药集团有限公司 利奈唑胺的新晶型及其制备方法
CN102399200B (zh) * 2011-12-14 2013-12-04 浙江新东港药业股份有限公司 一种利用悬浮结晶法制备利奈唑胺晶型ⅰ的方法
IN2014DN06213A (no) 2012-01-24 2015-10-23 Jubilant Life Sciences Ltd
WO2013120496A1 (en) 2012-02-14 2013-08-22 Pharmathen S.A. Process for the preparation of linezolid in crystalline form and salts thereof
CN102643245A (zh) * 2012-04-10 2012-08-22 杭州华东医药集团生物工程研究所有限公司 一种利奈唑胺晶型及其制备方法
WO2014071990A1 (en) 2012-11-09 2014-05-15 Synthon Bv Process for making linezolid
SG11202003537TA (en) * 2017-11-16 2020-05-28 Persica Pharmaceuticals Ltd Linezolid formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
CZ200788A3 (cs) * 1996-04-11 2017-01-25 Pfizer Inc. Způsob přípravy 5-aminomethyl substituovaných oxazolidinonaminů
JP2001522828A (ja) * 1997-11-07 2001-11-20 ファルマシア・アンド・アップジョン・カンパニー オキサゾリジノンの製法

Also Published As

Publication number Publication date
NO323459B1 (no) 2007-05-14
KR20070087178A (ko) 2007-08-27
AR027261A1 (es) 2003-03-19
EA004434B1 (ru) 2004-04-29
EE05197B1 (et) 2009-08-17
MXPA02007471A (es) 2002-12-13
CA2395603C (en) 2010-03-23
KR20080044358A (ko) 2008-05-20
MY122829A (en) 2006-05-31
NO20023654D0 (no) 2002-08-01
CN1394207A (zh) 2003-01-29
WO2001057035A1 (en) 2001-08-09
EP1255754A1 (en) 2002-11-13
CO5261555A1 (es) 2003-03-31
DK1255754T3 (da) 2005-08-22
SK287025B6 (sk) 2009-10-07
DE60111497T2 (de) 2006-05-18
ZA200205162B (en) 2003-09-29
CZ20022635A3 (cs) 2002-10-16
KR20020072300A (ko) 2002-09-14
HK1051196A1 (en) 2003-07-25
PE20011086A1 (es) 2001-10-04
CA2395603A1 (en) 2001-08-09
SI1255754T1 (sl) 2005-12-31
IL151010A0 (en) 2003-02-12
EA200200819A1 (ru) 2003-02-27
EP1255754B1 (en) 2005-06-15
CN1221547C (zh) 2005-10-05
AU3275501A (en) 2001-08-14
NZ520541A (en) 2004-02-27
ATE297920T1 (de) 2005-07-15
TWI297687B (en) 2008-06-11
PL356433A1 (en) 2004-06-28
HUP0301076A2 (hu) 2003-08-28
AU782138B2 (en) 2005-07-07
JP2003522175A (ja) 2003-07-22
SK9942002A3 (en) 2002-11-06
ES2242728T3 (es) 2005-11-16
HUP0301076A3 (en) 2004-06-28
CZ302292B6 (cs) 2011-02-09
BR0107667A (pt) 2002-10-08
KR100864745B1 (ko) 2008-10-22
DE60111497D1 (de) 2005-07-21
JP5235256B2 (ja) 2013-07-10
PT1255754E (pt) 2005-11-30
NO20065836L (no) 2002-08-01
EE200200420A (et) 2003-12-15
KR100781815B1 (ko) 2007-12-03

Similar Documents

Publication Publication Date Title
DK1255754T3 (da) Linezolid-krystalform II
DE60129488D1 (de) Anzeigegerät
DE60127364D1 (de) Antriebsvorrichtung
DE60132478D1 (de) Antriebsvorrichtung
DE60109777D1 (de) Plattenlaufwerk
CY2009001I2 (el) Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
DE60125415D1 (de) Formeinsatz
FR2810866B1 (fr) Presentoir
DE60011747D1 (de) Flüssigkristallanzeige
DE60101983D1 (de) Flüssigkristallanzeige
DE60114822D1 (de) Pen-pet-pen-polymerfilm
DE60112167D1 (de) Vibrator
DE50101124D1 (de) Antriebsvorrichtung
DE60136991D1 (de) Flüssigkristallprojektor
DE60111288D1 (de) Flüssigkristallanzeige
DE50109358D1 (de) Flüssigkristall-Anzeige
DE60114278D1 (de) Kalenderuhr
DE60200268D1 (de) Einkristallzüchtungsverfahren
FIU20000076U0 (fi) Kalanteri
DE50106225D1 (de) Antriebsvorrichtung
FI20000399A0 (fi) Kalanteri
DE50103447D1 (de) Antriebsvorrichtung
FR2817889B1 (fr) Coffrage
DE50101941D1 (de) Dermatologie-handlupe
FI4742U1 (fi) Kalanteri

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees